InfuSystem (NYSEAMERICAN:INFU) Raised to “Strong-Buy” at StockNews.com

InfuSystem (NYSEAMERICAN:INFU) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Wednesday.

InfuSystem Trading Up 0.3 %

Shares of INFU opened at $7.92 on Wednesday. The company has a current ratio of 1.95, a quick ratio of 1.54 and a debt-to-equity ratio of 0.56. InfuSystem has a 12 month low of $7.75 and a 12 month high of $11.44. The firm has a market cap of $168.38 million, a price-to-earnings ratio of 264.09 and a beta of 1.24.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in INFU. Barclays PLC purchased a new position in shares of InfuSystem during the 2nd quarter worth $35,000. BNP Paribas Arbitrage SNC boosted its stake in shares of InfuSystem by 3,895.0% during the 2nd quarter. BNP Paribas Arbitrage SNC now owns 4,834 shares of the medical instruments supplier’s stock worth $47,000 after acquiring an additional 4,713 shares during the last quarter. Bank of America Corp DE boosted its stake in shares of InfuSystem by 31.3% during the 1st quarter. Bank of America Corp DE now owns 6,398 shares of the medical instruments supplier’s stock worth $50,000 after acquiring an additional 1,526 shares during the last quarter. California State Teachers Retirement System purchased a new position in shares of InfuSystem during the 2nd quarter worth $58,000. Finally, UBS Group AG lifted its stake in shares of InfuSystem by 52.4% during the 4th quarter. UBS Group AG now owns 7,672 shares of the medical instruments supplier’s stock valued at $67,000 after buying an additional 2,637 shares in the last quarter. 71.13% of the stock is currently owned by institutional investors.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.